久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19 prnewswire
    November 30, 2021
    Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system.
  • Emmes Acquires Orphan Reach contractpharma
    May 13, 2021
    ?Emmes, a global, full-service CRO, has acquired Orphan Reach, a company headquartered in the UK with offices in Ireland, Germany, India, Canada, and the U.S., dedicated to clinical research in rare diseases.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service